Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PCRX | Common Stock | Sale | -$31.6K | -1.07K | -0.75% | $29.67 | 140K | Mar 6, 2024 | Direct | |
transaction | PCRX | Common Stock | Sale | -$871K | -28.3K | -20.13% | $30.81 | 112K | Mar 7, 2024 | Direct | F1 |
transaction | PCRX | Common Stock | Sale | -$2.75M | -90K | -80.27% | $30.60 | 22.1K | Mar 8, 2024 | Direct | F2 |
Id | Content |
---|---|
F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.550 to $30.965, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1 and 2. |
F2 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.300 to $30.860, inclusive. |